CS logo
small CS logo
National Cancer Institute of Mexico

Mexico City, Distrito Federal, Mexico
Hospital in Mexico City
Av. San Fernando 22, Belisario Domínguez Secc 16, Tlalpan, 14080 Ciudad de México, CDMX

About National Cancer Institute of Mexico


The Instituto Nacional de Cancerología is a public institution administered by the Mexican Secretariat of Health which specializes in the treatment of cancer. It is one of 12 specialized hospitals that provides public health services and trains new resident doctors.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at National Cancer Institute of Mexico


During the past decade, National Cancer Institute of Mexico conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute of Mexico" #1 collaborator was "Kimberly-Clark de México" with 1 trials as a collaborator, "Psicofarma S.A. de C.V." with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at National Cancer Institute of Mexico


According to Clinical.Site data, the most researched conditions in "National Cancer Institute of Mexico" are "Non-Small Cell Lung Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cervical Cancer" (1 trials), "Dysgeusia" (1 trials) and "EGFR" (1 trials). Many other conditions were trialed in "National Cancer Institute of Mexico" in a lesser frequency.

Clinical Trials Intervention Types at National Cancer Institute of Mexico


Most popular intervention types in "National Cancer Institute of Mexico" are "Drug" (4 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "2-octyl cyanoacrylate [InteguSEAL®]" (1 trials), "BIBW 2992" (1 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Hydralazine/Magnesium" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Cancer Institute of Mexico


The vast majority of trials in "National Cancer Institute of Mexico" are 7 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at National Cancer Institute of Mexico


Currently, there are NaN active trials in "National Cancer Institute of Mexico". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National Cancer Institute of Mexico, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Cancer Institute of Mexico, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".